Last edition
News about "AI-powered drug development"
LG AI Research Partners with D&D Pharmatech for Oral Peptide Drug Discovery
LG AI Research and D&D Pharmatech have partnered to accelerate next-generation oral peptide drug discovery using advanced AI technologies. The collaboration aims to enhance drug development efficiency and strengthen LG’s leadership in the rapidly growing AI-driven biopharmaceutical market.
AI-powered Drug Development | 18/06/2026 | By News Bureau
Tempus Launches Next-Generation Lens AI Platform for Oncology Drug Development
Tempus has unveiled the next-generation Lens platform, expanding its agentic AI capabilities for oncology drug development by leveraging over a decade of longitudinal real-world data and advanced analytics to generate actionable insights for biopharma research, clinical development, and precision medicine.
AI-powered Drug Development | 01/06/2026 | By News Bureau | 419
Parexel Launches ParexelAI to Speed Up Clinical Development
Parexel launches ParexelAI, a proprietary Artificial Intelligence (AI) platform designed to accelerate clinical development by improving trial speed, efficiency, and data quality for sponsors and patients.
AI-powered Drug Development | 20/05/2026 | By News Bureau | 154
Dyno Therapeutics Unveils Next-Generation AI-Engineered AAV Capsids for CNS and Muscle Gene Delivery
Dyno Therapeutics introduced new AAV gene delivery capsids for central nervous system and muscular applications, highlighting enhanced cross-species transduction, reduced liver targeting and scalable manufacturing potential for next-generation genetic medicines.
AI-powered Drug Development | 16/05/2026 | By News Bureau | 172
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy